Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non Operating Income: 2014-2024

Historic Other Non Operating Income for Collegium Pharmaceutical (COLL) over the last 6 years, with Dec 2024 value amounting to -$11.3 million.

  • Collegium Pharmaceutical's Other Non Operating Income was N/A to -$4.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$27.5 million, marking a year-over-year change of. This contributed to the annual value of -$11.3 million for FY2024, which is 51.80% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Other Non Operating Income of -$11.3 million as of FY2024, which was up 51.80% from -$23.5 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Other Non Operating Income registered a high of -$11.3 million during FY2024, and its lowest value of -$23.5 million during FY2023.
  • In the last 2 years, Collegium Pharmaceutical's Other Non Operating Income had a median value of -$17.4 million in 2023 and averaged -$17.4 million.
  • Data for Collegium Pharmaceutical's Other Non Operating Income shows a peak YoY spiked of 51.80% (in 2024) over the last 5 years.
  • Over the past 2 years, Collegium Pharmaceutical's Other Non Operating Income (Yearly) stood at -$23.5 million in 2023, then spiked by 51.80% to -$11.3 million in 2024.